HIGHLIGHTS
- who: Ammad Mahmood from the School of Psychology and Neuroscience, Queen Elizabeth University Hospital, University of Glasgow, Glasgow, UK have published the research: Tenecteplase or Alteplase: What Is the Thrombolytic Agent of the Future?, in the Journal: (JOURNAL)
- what: The authors aimed to examine the evidence base for each drug and discuss their use in varying patient populations in Recent findings Several trials comparing and have reported very recently with the results of the ACT trial strengthening the argument in favour of noninferiority of to Ongoing trials such as ATTEST-2 are of interest and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.